BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 25962113)

  • 1. Structure based in silico analysis of quinolone resistance in clinical isolates of Salmonella Typhi from India.
    Kumar M; Dahiya S; Sharma P; Sharma S; Singh TP; Kapil A; Kaur P
    PLoS One; 2015; 10(5):e0126560. PubMed ID: 25962113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. First isolation of ciprofloxacin-resistant Salmonella enterica serovar Typhi in Taiwan.
    Lee CJ; Su LH; Huang YC; Chiu CH
    J Microbiol Immunol Infect; 2013 Dec; 46(6):469-73. PubMed ID: 23465712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular characterization of ciprofloxacin-resistant Salmonella enterica serovar Typhi and Paratyphi A causing enteric fever in India.
    Gaind R; Paglietti B; Murgia M; Dawar R; Uzzau S; Cappuccinelli P; Deb M; Aggarwal P; Rubino S
    J Antimicrob Chemother; 2006 Dec; 58(6):1139-44. PubMed ID: 17071955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of mechanisms involved in reduced susceptibility to ciprofloxacin in Salmonella enterica serotypes Typhi and Paratyphi A isolates from travellers to Southeast Asia.
    Hassing RJ; Menezes GA; van Pelt W; Petit PL; van Genderen PJ; Goessens WH
    Int J Antimicrob Agents; 2011 Mar; 37(3):240-3. PubMed ID: 21227657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel restriction enzyme SSiI for the detection of mutation in GyrA gene of Salmonella enterica serovar Typhi.
    Agrawal P; Kapila K; Kumar S; Ghosh AN; Maurya AK
    Indian J Pathol Microbiol; 2010; 53(3):509-12. PubMed ID: 20699513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The acquisition of full fluoroquinolone resistance in Salmonella Typhi by accumulation of point mutations in the topoisomerase targets.
    Turner AK; Nair S; Wain J
    J Antimicrob Chemother; 2006 Oct; 58(4):733-40. PubMed ID: 16895934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism of binding of fluoroquinolones to the quinolone resistance-determining region of DNA gyrase: towards an understanding of the molecular basis of quinolone resistance.
    Madurga S; Sánchez-Céspedes J; Belda I; Vila J; Giralt E
    Chembiochem; 2008 Sep; 9(13):2081-6. PubMed ID: 18677735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased quinolone resistance among typhoid Salmonella isolated from Egyptian patients.
    Saleh FO; Ahmed HA; Khairy RM; Abdelwahab SF
    J Infect Dev Ctries; 2014 May; 8(5):661-5. PubMed ID: 24820472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure based drug discovery and in vitro activity testing for DNA gyrase inhibitors of Salmonella enterica serovar Typhi.
    Sharma P; Kumar M; Dahiya S; Sood S; Das BK; Kaur P; Kapil A
    Bioorg Chem; 2020 Nov; 104():104244. PubMed ID: 32966903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced susceptibility to ciprofloxacin and gyra gene mutation in North Indian strains of Salmonella enterica serotype Typhi and serotype Paratyphi A.
    Renuka K; Kapil A; Kabra SK; Wig N; Das BK; Prasad VV; Chaudhry R; Seth P
    Microb Drug Resist; 2004; 10(2):146-53. PubMed ID: 15256030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of mutations in the gyrA gene in fluoroquinolone resistance Salmonella enterica serotypes typhi and paratyphi A isolated from the Infectious Diseases Hospital, Kuwait.
    Dimitrov T; Dashti AA; Albaksami O; Jadaon MM
    J Clin Pathol; 2010 Jan; 63(1):83-7. PubMed ID: 19889623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characteristics of Resistance Mechanisms and Molecular Epidemiology of Fluoroquinolone-Nonsusceptible
    Okanda T; Haque A; Ehara T; Huda Q; Ohkusu K; Miah RA; Matsumoto T
    Microb Drug Resist; 2018 Dec; 24(10):1460-1465. PubMed ID: 29894282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug resistance patterns in Salmonella enterica subspecies enterica serotype Typhi strains isolated over a period of two decades, with special reference to ciprofloxacin and ceftriaxone.
    Nath G; Maurya P
    Int J Antimicrob Agents; 2010 May; 35(5):482-5. PubMed ID: 20188522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of resistant mutants of Salmonella enterica serotype Typhi under ciprofloxacin selective pressure.
    Dahiya S; Kapil A; Lodha R; Kumar R; Das BK; Sood S; Kabra SK
    Indian J Med Res; 2014 May; 139(5):746-53. PubMed ID: 25027085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiology of Multidrug Resistance among Salmonella enterica serovars typhi and paratyphi A at a Tertiary Pediatric Hospital in India Over a Decade; In-silico Approach to Elucidate the Molecular Mechanism of Quinolone Resistance.
    Manoharan A; Dey D; Putlibai S; Ramaiah S; Anbarasu A; Balasubramanian S
    Int J Infect Dis; 2022 Jun; 119():146-149. PubMed ID: 35364283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimicrobial resistance trends in blood culture positive Salmonella Typhi isolates from Pondicherry, India, 2005-2009.
    Menezes GA; Harish BN; Khan MA; Goessens WH; Hays JP
    Clin Microbiol Infect; 2012 Mar; 18(3):239-45. PubMed ID: 21714829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emergence and properties of fluoroquinolone resistant Salmonella enterica serovar Typhi strains isolated from Nepal in 2002 and 2003.
    Nobthai P; Serichantalergs O; Wongstitwilairoong B; Srijan A; Bodhidatta L; Malla S; Mason CJ
    Southeast Asian J Trop Med Public Health; 2010 Nov; 41(6):1416-22. PubMed ID: 21329318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suitable disk antimicrobial susceptibility breakpoints defining Salmonella enterica serovar Typhi isolates with reduced susceptibility to fluoroquinolones.
    Parry CM; Thuy CT; Dongol S; Karkey A; Vinh H; Chinh NT; Duy PT; Thieu Nga TV; Campbell JI; Van Minh Hoang N; Arjyal A; Bhutta ZA; Bhattacharya SK; Agtini MD; Dong B; Canh DG; Naheed A; Wain J; Tinh Hien T; Basnyat B; Ochiai L; Clemens J; Farrar JJ; Dolecek C; Baker S
    Antimicrob Agents Chemother; 2010 Dec; 54(12):5201-8. PubMed ID: 20837759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of mutations in DNA gyrase genes on quinolone resistance in Campylobacter jejuni.
    Changkwanyeun R; Yamaguchi T; Kongsoi S; Changkaew K; Yokoyama K; Kim H; Suthienkul O; Usui M; Tamura Y; Nakajima C; Suzuki Y
    Drug Test Anal; 2016 Oct; 8(10):1071-1076. PubMed ID: 26857529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased susceptibility to fluoroquinolones and gyrA gene mutation in the Salmonella enterica serovar Typhi and Paratyphi A isolated in Katmandu, Nepal, in 2003.
    Shirakawa T; Acharya B; Kinoshita S; Kumagai S; Gotoh A; Kawabata M
    Diagn Microbiol Infect Dis; 2006 Apr; 54(4):299-303. PubMed ID: 16466897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.